aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Tr
LIFE: aTyr Pharma, Inc.
2021-09-13 07:30:00
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
2021-09-13 07:30:00
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis